A$0.175 BRN.AX BrainChip ASX after hours: AI stock outlook Jan 26, 2026
BRN.AX stock trades at A$0.175 in after hours trade on 26 January 2026, reflecting calm intraday activity between A$0.17 and A$0.18. Investors following BrainChip Holdings Ltd (BRN.AX) are watching execution on Akida neuromorphic chips and upcoming results ahead of an earnings announcement on 2026-03-04. This piece gives a concise ASX-focused review of price drivers, financials, technical setup and our model forecast to help investors assess BRN.AX stock risks and opportunities in the AI stocks theme.
BRN.AX stock snapshot and recent moves
BrainChip Holdings Ltd (BRN.AX) closed at A$0.175 with volume 4,616,639 today in after hours trade. The 52-week range is A$0.155 – A$0.415 and market capitalisation is A$412,730,208. Short-term momentum shows a 1M change of +2.94% and 1Y change of -53.33%, linking recent volatility to mixed adoption signals for edge-AI products.
BRN.AX stock financials and valuation metrics
BrainChip reports trailing EPS -0.02 and a negative PE of -8.75, reflecting losses as the business scales. Key ratios include Price/Sales 216.31, Price/Book 16.46 and current ratio 5.18, indicating cash coverage but high valuation multiples versus revenue. Revenue growth for FY 2024 was +71.55%, while operating margins remain negative at -17.03%. These figures frame BRN.AX stock as a high-growth, capital-efficient tech developer with profitability still to be proven.
BRN.AX stock technicals and trading signals
Technically BRN.AX shows RSI 60.30 and CCI 137.05 (overbought), with Bollinger Bands at 0.15/0.17/0.19. Average 50-day price is A$0.1756 and 200-day is A$0.2031, suggesting the stock sits near short-term support but below longer-term average. Average daily volume 8,426,847 vs today’s 4,616,639 points to lighter intraday liquidity and potential volatility around news events.
BRN.AX stock sector context and competitive position
BrainChip competes in the semiconductors and edge-AI sector within the ASX Technology universe. The Technology sector average P/B is 2.00, whereas BRN.AX P/B is 16.46, showing a valuation premium for its neuromorphic IP. Sector momentum is muted YTD at +0.47%, which places additional performance pressure on early-stage AI hardware names to deliver commercial wins.
Meyka AI rates BRN.AX with a score out of 100 and forecast
Meyka AI rates BRN.AX with a score of 64.84 out of 100 — Grade B, Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of A$0.190. Versus the current price A$0.175, that implies an upside of +8.79%. Forecasts are model-based projections and not guarantees.
BRN.AX stock risks and near-term catalysts
Primary risks for BRN.AX stock are continued negative margins, long sales cycles for embedded semiconductor deals, and high valuation metrics relative to revenue. Near-term catalysts include the FY 2025 earnings release on 2026-03-04, new Akida design wins, and any supply-chain or partner announcements. Management execution on commercial traction will be the main price driver over the next 6 to 12 months.
Final Thoughts
Key takeaways for BRN.AX stock: BrainChip trades at A$0.175 in after hours on 26 January 2026 with a market cap of A$412.73m, strong short-term volatility and a mixed financial profile. The company shows solid revenue growth but negative profitability and elevated valuation multiples (P/S 216.31, P/B 16.46). Technicals suggest near-term support near A$0.17 but limited short-term momentum without fresh commercial news. Meyka AI’s model projects A$0.190 for the year, implying roughly +8.79% upside versus A$0.175; forecasts are not guarantees. For investors focused on AI stocks, BRN.AX offers exposure to niche neuromorphic IP and low-power edge chips, but reward depends on sales execution and margin improvement. Use the upcoming earnings release, partner announcements and order flow as decision points. For real-time quotes and a short news feed see MarketWatch coverage and for international listing notes see the Nasdaq summary source. For an ASX stock dashboard, view our Meyka analyis page for BRN.AX Meyka stock page. Meyka AI is an AI-powered market analysis platform and this article frames data-driven insights, not investment advice.
FAQs
What is the current price and market cap of BRN.AX stock?
BRN.AX stock trades at A$0.175 after hours on 26 Jan 2026 with a market capitalisation of A$412,730,208. Volume today was 4,616,639 shares.
What forecast does Meyka AI give for BRN.AX stock?
Meyka AI’s forecast model projects a yearly price of A$0.190, implying approximately +8.79% upside versus the current A$0.175. Forecasts are model projections and not guarantees.
When is the next earnings announcement for BrainChip (BRN.AX)?
BrainChip’s next earnings announcement is scheduled for 2026-03-04. That release is a key near-term catalyst for BRN.AX stock and for assessing revenue and margin progress.
What are the main risks for BRN.AX stock investors?
Key risks include continued negative margins, slow enterprise adoption of neuromorphic chips, tight liquidity on news, and high valuation multiples versus revenue. Execution on product wins is critical for BRN.AX stock performance.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
